Lion Biotechnologies (LBIO) – Hot FDA News
-
Lion Biotechnologies (LBIO) Reports Updated Data from Ongoing LN-144 Phase 2 Clinical Trial at ASCO Meetings
-
Lion Bio (LBIO) Announces NCI Presentation of Updated TIL Phase 2 Data in Metastatic Melanoma
Back to LBIO Stock Lookup